Docetaxel

Land: New Zealand

Språk: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv ingrediens:

Docetaxel trihydrate 135.7mg equivalent to anhydrous docetaxel 120 mg

Tilgjengelig fra:

REX Medical Ltd

INN (International Name):

Docetaxel trihydrate 135.7 mg (equivalent to anhydrous docetaxel 120 mg)

Dosering :

120 mg/mL

Legemiddelform:

Concentrate for infusion

Sammensetning:

Active: Docetaxel trihydrate 135.7mg equivalent to anhydrous docetaxel 120 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Enheter i pakken:

Vial, glass, Diluent, 9 mL

Klasse:

Prescription

Resept typen:

Prescription

Produsert av:

Cipla Ltd

Indikasjoner:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Produkt oppsummering:

Package - Contents - Shelf Life: Vial, glass, Diluent - 9 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 120 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Autorisasjon dato:

2006-06-23